<DOC>
	<DOCNO>NCT02974829</DOCNO>
	<brief_summary>The purpose study conduct investigator initiate observational study continue follow China subset study participant another 5 year complete participation REALM Study</brief_summary>
	<brief_title>REALM China Extension Study</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<criteria>1 . Patients complete REALM Study China 2 . Patients willing sign consent continue antiviral treatment posttreatment follow , agree his/her legacy data blood/liver histology sample collect REALM Study may use analysis plan new study . 1 . Patients provide consent participate study ; 2 . Patients formally enrol investigational drug clinical trial REALM study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Chronic Hepatitis B</keyword>
</DOC>